GlassScriptPhysician profile
Robert H Wagner
NPI 1457329997
$2,675.48
in general payments reported to CMS, 2019-2025
29 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $392 · 2021: $540 · 2022: $358 · 2023: $53.90 · 2024: $122 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $566.18 | 2019-2022 | |
| Vertos Medical, INC. | $180.73 | 2021 | |
| Depuy Synthes Sales INC. | $169.37 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Biotronik Nro, INC. | $143.23 | 2025 | Prospera |
| Abbott Laboratories | $137.49 | 2019-2021 | |
| Grt US Holding, INC. | $130.00 | 2022 | |
| Arbor Pharmaceuticals, INC. | $128.39 | 2020-2021 | |
| Merz North America, INC. | $123.91 | 2020 | |
| Stryker Corporation | $122.59 | 2021 | |
| Allergan, INC. | $116.90 | 2019 | |
| Abbvie INC. | $107.08 | 2024-2025 | |
| Medtronic USA, INC. | $98.83 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $90.49 | 2024-2025 | |
| Fidia Pharma USA INC. | $79.28 | 2019-2024 | Hymovis |
| Boston Scientific Corporation | $73.27 | 2022-2025 | Wavewriter Alpha Prime 16 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $53.90 | 2023 | Durolane |
| Teva Pharmaceuticals USA, INC. | $44.24 | 2019 | |
| Pacira Therapeutics, INC. | $43.96 | 2019 | |
| Arteriocyte Medical Systems, INC. | $40.61 | 2020 | |
| Vertical Pharmaceuticals, LLC | $32.98 | 2019 | |
| Lundbeck LLC | $32.84 | 2020-2021 | |
| Si-Bone, INC. | $28.86 | 2025 | |
| Averitas Pharma INC. | $25.04 | 2025 | Qutenza |
| Mdd US Operations, LLC | $21.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.61 | 2025 | Zilretta |
| Scilex Pharmaceuticals INC. | $18.66 | 2019 | |
| Collegium Pharmaceutical, INC. | $16.39 | 2019 | |
| Electronic Waveform Lab, INC. | $16.15 | 2025 | |
| Daiichi Sankyo INC. | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.